Giuseppe Gargiulo

Showing 1-12 of 12 articles

Coronary interventions

Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score

Gragnano F, Jolly S, Mehta S, Branca M, van Klaveren D, Frigoli E, Gargiulo G, Leonardi S, Vranckx P, Di Maio D, Monda E, Fimiani L, Fioretti V, Chianese S, Andò G, Esposito G, Sangiorgi G, Biondi-Zoccai G, Heg D, Calabrò P, Windecker S, Romagnoli E, Valgimigli M

August 11, 2021 | 10.4244/EIJ-D-21-00441

Coronary interventions

Impact of Clinical Presentation on Bleeding Risk after Percutaneous Coronary Intervention and Implications for the ARC-HBR Definition

Gragnano F, Spirito A, Corpataux N, Vaisnora L, Galea R, Gargiulo G, Siontis G, Praz F, Lanz J, Billinger M, Hunziker L, Stortecky S, Pilgrim T, Bär S, Ueki Y, Capodanno D, Urban P, Pocock S, Mehran R, Heg D, Windecker S, Räber L, Valgimigli M

June 8, 2021 | 10.4244/EIJ-D-21-00181

Consolidating the value of the standardised ARC-HBR definition

Gargiulo G, Esposito G

February 19, 2021 | 10.4244/EIJV16I14A202

Cardiovascular mortality and morbidity in patients undergoing percutaneous coronary intervention after out-of-hospital cardiac arrest: a systematic review and meta-analysis

Spirito A, Gargiulo G, Siontis G, Mitsis A, Billinger M, Windecker S, Valgimigli M

February 5, 2021 | 10.4244/EIJ-D-20-00221

Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores

Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, Gragnano F, Gargiulo G, Siontis G, Praz F, Lanz J, Hunziker L, Stortecky S, Pilgrim T, Heg D, Valgimigli M, Windecker S, Räber L

August 28, 2020 | 10.4244/EIJ-D-20-00052

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Coronary interventions

State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation – past, present and future perspectives

Gargiulo G, Valgimigli M, Capodanno D, Bittl J

August 25, 2017 | 10.4244/EIJ-D-17-00468

Coronary interventions

Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial

Piccolo R, Magnani G, Ariotti S, Gargiulo G, Marino M, Santucci A, Franzone A, Tebaldi M, Heg D, Windecker S, Valgimigli M

May 15, 2017 | 10.4244/EIJ-D-16-00497

Interventions for valvular disease

A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation

Sannino A, Gargiulo G, Schiattarella G, Perrino C, Stabile E, Losi M-A, Galderisi M, Izzo R, de Simone G, Trimarco B, Esposito G

October 10, 2016

Coronary interventions

One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice

Capranzano P, Longo G, Tamburino Cl, Gargiulo G, Ohno Y, Francaviglia B, La Manna A, Di Salvo M-E, Grasso C, Sgroi C, Capodanno D, Tamburino C

June 10, 2016 | 10.4244/EIJV12I2A28

Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation

Barbanti M, Capranzano P, Ohno Y, Gulino S, Sgroi C, Imme S, Tamburino Cl, Cannata S, Patane M, Di Stefano D, Todaro D, Di Simone E, Deste W, Gargiulo G, Capodanno D, Grasso C, Tamburino C

October 20, 2015 | 10.4244/EIJV11I6A137

Interventions for valvular disease

Antithrombotic therapy in TAVI patients: changing concepts

Gargiulo G, Collet J, Valgimigli M

September 17, 2015 | 10.4244/EIJV11SWA28

Latest news

NEW ISSUE

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

AHEAD OF PRINT

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

AHEAD OF PRINT

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

EDITORIAL

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

EDITORIAL

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

EDITORIAL

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?